The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update
- PMID: 32511106
- DOI: 10.1097/ADM.0000000000000633
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update
Erratum in
-
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update: Erratum.J Addict Med. 2020 May/Jun;14(3):267. doi: 10.1097/ADM.0000000000000683. J Addict Med. 2020. PMID: 32487948 No abstract available.
References
-
- Hagan J, Shaw J, Duncan P. Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents. Pocket Guide (3rd Ed.). Elk Grove Village, IL: American Academy of Pediatrics; 2008.
-
- Mee-Lee D, Shulman GD, Fishman MJ. The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occuring Conditions (3rd Ed.). The Change Companies; 2013.
-
- METHADOSE (methadone hydrochloride oral concentrate USP) [Package Insert]. 2016. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017116s029lbl.pdf.
-
- Sigmon SC, Bisaga A, Nunes EV, O’Connor PG, Kosten T, Woody G. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice. Am J Drug Alcohol Abuse 2012; 38 (3):187–199. doi:10.3109/00952990.2011.653426. - DOI
-
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders: DSM-5. 2013; Washington, D.C:American Psychiatric, doi:10.1016/j.drugalcdep.2009.05.021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical